May 2013 Archive
UM Ventures Congratulates UM Baltimore Licensee, Hemerus Medical, LLC, on FDA Approval of SOLX® Whole Blood Collection System; Hemerus Acquired by Haemonetics Corporation
Saturday, May 25, 2013
Haemonetics Corporation (NYSE:HAE) announced that it has completed its previously announced acquisition of the assets of Hemerus Medical, LLC ("Hemerus"), a Minnesota-based company that develops innovative technologies for the collection of whole blood and for the processing and storage of blood... read more
UM Ventures Congratulates Tokai Pharma on Recent Fundraising Success
Wednesday, May 15, 2013
Tokai’s lead drug candidate, galeterone (TOK-001), is currently in Phase 2 clinical trials as a new therapy against prostate cancer. Galeterone was discovered by a UM Baltimore research team led by Prof. Angela Brodie and Prof. Vincent Njar. Read more at:http://tokaipharma.com/pdfs/Tokai-Series-E-... read more
USM Board of Regents Honors 3 Winners of Inaugural Entrepreneur of the Year Award: Winners' Entrepreneurial Success Reflected in Support of UM Ventures
Tuesday, May 14, 2013
Adelphi, Md. (May 14, 2013) -- As part of a signature goal of the University System of Maryland (USM) Strategic Plan 2020 to increase technology commercialization efforts, the USM Board of Regents honored three faculty members today with the inaugural USM Board of Regents Entrepreneur of the Year... read more
Small State, Big Ideas — Maryland Is for Inventors
Friday, May 10, 2013
It’s true that, geographically speaking, Maryland is a small state. But as the old saying goes, “Good things come in small packages,” and that is especially true when it comes to the resources, advice and technical expertise that Maryland offers inventors and technology entrepreneurs. From... read more
VisiSonics Profiled in BMore Media Story
Tuesday, May 7, 2013
VisiSonics Corporation is seeking $750,000 in its first round of funding from angel investors so the College Park startup can launch its first software product, RealSpace, by the fall. VisiSonics produces software and hardware to improve the sound spatialization, or three-dimensional perception,... read more
UMB Licensee Receives Avon Foundation Grant
Monday, May 6, 2013
UM Ventures congratulates UM Baltimore startup A&G Pharmaceutical on its $300,000 research grant from Avon Foundation. A&G is developing a blood test for use in detection and monitoring of breast cancer using its proprietary biomarker GP88. This grant from the Avon Foundation is the third A... read more